(Q40744024)

23 September 2017

title

Pseudorabies virus (PRV) is protected from complement attack by cellular factors and glycoprotein C (gC). (English)

1 reference

23 September 2017

Kohshi Maeda

1

1 reference

23 September 2017

Sunao Hayashi

2

1 reference

23 September 2017

Yoshikuni Tanioka

3

1 reference

23 September 2017

Yasunobu Matsumoto

4

1 reference

23 September 2017

Haruki Otsuka

5

1 reference

23 September 2017

publication date

1 March 2002

1 reference

23 September 2017

1 reference

23 September 2017

volume

84

1 reference

23 September 2017

issue

1-2

1 reference

23 September 2017

page(s)

79-87

1 reference

Brefeldin A arrests the maturation and egress of herpes simplex virus particles during infection

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900417-8

7 January 2021

CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900417-8

7 January 2021

Complement component C3b binds directly to purified glycoprotein C of herpes simplex virus types 1 and 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900417-8

7 January 2021

Viral activation of the coagulation cascade: molecular interactions at the surface of infected endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900417-8

7 January 2021

Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900417-8

7 January 2021

The phospholipid composition of extracellular herpes simplex virions differs from that of host cell nuclei

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900417-8

7 January 2021

Egress of alphaherpesviruses: comparative ultrastructural study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900417-8

7 January 2021

Homologous species restriction in lysis of erythrocytes by terminal complement proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900417-8

7 January 2021

Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activities

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900417-8

7 January 2021

Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900417-8

7 January 2021

The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900417-8

7 January 2021

Binding of properdin to solid-phase immune complexes: critical role of the classical activation pathway of complement.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900417-8

7 January 2021

Control of Aujeszky's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900417-8

7 January 2021

Viral interference with antibody and complement

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900417-8

7 January 2021

Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900417-8

7 January 2021

Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900417-8

7 January 2021

Regulation of complement

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900417-8

7 January 2021

Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900417-8

7 January 2021

A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complement

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900417-8

7 January 2021

The requirement of localized, CR2-mediated, alternative pathway activation of complement for covalent deposition of C3 fragments on normal B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900417-8

7 January 2021

Binding of complement component C3b to glycoprotein C is modulated by sialic acid on herpes simplex virus type 1-infected cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900417-8

7 January 2021

Isolation from human erythrocytes of a new membrane protein which inhibits the formation of complement transmembrane channels

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900417-8

7 January 2021

Herpes simplex virus type 1-induced hemagglutination: glycoprotein C mediates virus binding to erythrocyte surface heparan sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900417-8

7 January 2021

Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900417-8

7 January 2021

10.1016/S0168-1702(01)00417-8

Identifiers

DOI

1 reference

23 September 2017

1 reference